Lemuteporfin
- Generic Name
- Lemuteporfin
- Drug Type
- Small Molecule
- Chemical Formula
- C44H48N4O10
- CAS Number
- 215808-49-4
- Unique Ingredient Identifier
- EZ109VJ012
- Background
Lemuteporfin, under development by QLT Incorporated, is a benzoporphyrin-derived chlorin-like photosensitizer. It is intended for the treatment of beign prostatic hyperplasia.
- Indication
Intended for the treatment of benign prostatic hyperplasia and prostrate disorders.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath